Holdings of Artia Global Partners LP
42 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 76.9 % of the equity sleeve
Sector breakdown
- Health care 47.4 %
- Industrials 2.7 %
- Unattributed 49.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 75.7 %
- FR 16.8 %
- NL 5.5 %
- DK 1.0 %
- KY 1.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 38 | 300.3M $ | 75.65 % |
| 2 | FR | 1 | 66.9M $ | 16.85 % |
| 3 | NL | 1 | 21.7M $ | 5.47 % |
| 4 | DK | 1 | 4.1M $ | 1.02 % |
| 5 | KY | 1 | 4M $ | 1.00 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Insmed Inc | 628,712 | 102.8M $ | |
| 2 | Abivax SA | 600,747 | 66.9M $ | |
| 3 | Eli Lilly & Co | 38,220 | 35.2M $ | |
| 4 | Trevi Therapeutics Inc | 2,013,602 | 24M $ | |
| 5 | Argenx SE | 29,739 | 21.7M $ | |
| 6 | Dianthus Therapeutics Inc | 162,990 | 13.7M $ | |
| 7 | Revolution Medicines Inc | 124,990 | 12.2M $ | |
| 8 | Ionis Pharmaceuticals Inc | 144,376 | 10.8M $ | |
| 9 | EyePoint Inc | 767,098 | 9.9M $ | |
| 10 | Quest Diagnostics Inc | 40,817 | 8M $ | |
| 11 | Alumis Inc | 325,046 | 7.2M $ | |
| 12 | Viking Therapeutics Inc | 180,731 | 5.9M $ | |
| 13 | Merck & Co Inc | 46,700 | 5.6M $ | |
| 14 | Terns Pharmaceuticals Inc | 104,800 | 5.5M $ | |
| 15 | Johnson & Johnson | 22,600 | 5.5M $ | |
| 16 | Sionna Therapeutics Inc | 119,741 | 4.8M $ | |
| 17 | Scholar Rock Holding Corp | 96,285 | 4.7M $ | |
| 18 | Rapport Therapeutics Inc | 138,508 | 4.3M $ | |
| 19 | Ascendis Pharma A/S | 17,740 | 4.1M $ | |
| 20 | Belite Bio Inc | 24,989 | 4M $ | |
| 21 | Mineralys Therapeutics Inc | 137,800 | 3.7M $ | |
| 22 | Palisade Bio Inc | 1,992,367 | 3.5M $ | |
| 23 | Biogen Inc | 18,437 | 3.4M $ | |
| 24 | ProKidney Corp | 1,806,939 | 3.2M $ | |
| 25 | AbbVie Inc | 14,500 | 3.2M $ | |
| 26 | United Therapeutics Corp | 5,000 | 3M $ | |
| 27 | Protagonist Therapeutics Inc | 22,931 | 2.4M $ | |
| 28 | Soleno Therapeutics Inc | 68,490 | 2.3M $ | |
| 29 | BrightSpring Health Services Inc | 53,800 | 2.3M $ | |
| 30 | Travere Therapeutics Inc | 70,700 | 2.1M $ | |
| 31 | Edgewise Therapeutics Inc | 65,500 | 2.1M $ | |
| 32 | Celcuity Inc | 15,576 | 1.8M $ | |
| 33 | Bridgebio Pharma Inc | 20,400 | 1.5M $ | |
| 34 | Cytokinetics Inc | 16,300 | 1.1M $ | |
| 35 | Enliven Therapeutics Inc | 20,900 | 819.3K $ | |
| 36 | Praxis Precision Medicines Inc | 2,500 | 805.5K $ | |
| 37 | Tenax Therapeutics Inc | 42,080 | 672.9K $ | |
| 38 | Kodiak Sciences Inc | 17,019 | 648.8K $ | |
| 39 | Nuvalent Inc | 4,900 | 502K $ | |
| 40 | Apogee Therapeutics Inc | 5,886 | 495.4K $ | |
| 41 | AVALO THERAPEUTICS INC | 28,970 | 432.5K $ | |
| 42 | PepGen Inc | 205,324 | 363.4K $ | |